{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valbenazine+Oral+Capsule", "query": { "intervention": "Valbenazine Oral Capsule" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valbenazine+Oral+Capsule&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-14T11:07:15.439Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05110157", "title": "Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Valbenazine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 442, "start_date": "2021-11-29", "completion_date": "2025-02-18", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 50, "location_summary": "Phoenix, Arizona • Rogers, Arkansas • Anaheim, California + 39 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bellflower", "state": "California" }, { "city": "Culver City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05110157" }, { "nct_id": "NCT05859698", "title": "Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Bipolar Disorder", "Major Depressive Disorder", "Tardive Dyskinesia" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2023-05-09", "completion_date": "2024-12-27", "has_results": true, "last_update_posted_date": "2026-01-16", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 18, "location_summary": "Bryant, Arkansas • Anaheim, California • Orange, California + 15 more", "locations": [ { "city": "Bryant", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Bonita Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05859698" }, { "nct_id": "NCT03698331", "title": "The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tardive Dyskinesia (TD)" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 89, "start_date": "2018-09-14", "completion_date": "2019-04-03", "has_results": true, "last_update_posted_date": "2020-06-04", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 16, "location_summary": "Anaheim, California • Glendale, California • Norwalk, California + 11 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Norwalk", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Bernardino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03698331" }, { "nct_id": "NCT03325010", "title": "Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tourette Syndrome" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 127, "start_date": "2017-10-05", "completion_date": "2018-11-16", "has_results": true, "last_update_posted_date": "2021-06-28", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 34, "location_summary": "Sun City, Arizona • Rogers, Arkansas • Anaheim, California + 27 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Clarita", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03325010" }, { "nct_id": "NCT04400331", "title": "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chorea, Huntington" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 154, "start_date": "2020-09-18", "completion_date": "2025-11-05", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 31, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04400331" }, { "nct_id": "NCT03530293", "title": "Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tourette Syndrome" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 81, "start_date": "2018-04-17", "completion_date": "2019-07-16", "has_results": true, "last_update_posted_date": "2022-05-17", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 48, "location_summary": "Sun City, Arizona • Little Rock, Arkansas • Rogers, Arkansas + 43 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03530293" }, { "nct_id": "NCT01733121", "title": "NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tardive Dyskinesia" ], "interventions": [ { "name": "NBI-98854", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 102, "start_date": "2012-12", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2017-08-10", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 21, "location_summary": "Costa Mesa, California • Fountain Valley, California • Oceanside, California + 17 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01733121" }, { "nct_id": "NCT05206513", "title": "Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyskinesia", "Cerebral Palsy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Valbenazine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "6 Years to 70 Years" }, "enrollment_count": 86, "start_date": "2022-04-15", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 19, "location_summary": "San Diego, California • Aurora, Colorado • Stamford, Connecticut + 16 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Gulf Breeze", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05206513" }, { "nct_id": "NCT04102579", "title": "Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chorea, Huntington" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 128, "start_date": "2019-11-13", "completion_date": "2021-10-26", "has_results": true, "last_update_posted_date": "2023-10-11", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04102579" }, { "nct_id": "NCT02274558", "title": "A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tardive Dyskinesia" ], "interventions": [ { "name": "NBI-98854", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 234, "start_date": "2014-10", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-07-11", "last_synced_at": "2026-09-14T11:07:15.439Z", "location_count": 48, "location_summary": "Little Rock, Arkansas • Anaheim, California • Glendale, California + 45 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02274558" } ] }